DNA-based immunization by in vivo transfection of dendritic cells

Nature Medicine

Volumn 2, Issue 10, 1996, Pages 1122-1128

  Condon, Cal ^a   Watkins, Simon C ^a   Celluzzi, Christina M ^a   Thompson, Kathleen ^a   Falo Jr , Louis D ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DNA TRANSFECTION; FEMALE; FLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; ULTRASTRUCTURE; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BIOLISTICS; CELL MOVEMENT; DENDRITIC CELLS; EPITOPES; FEASIBILITY STUDIES; FEMALE; H-2 ANTIGENS; IMMUNIZATION; LYMPH NODES; LYMPHOMA, T-CELL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINES, DNA;

ANIMALIA;

EID: 0029820526     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1096-1122     Document Type: Article

References (34)

1. Doherty, P.C., Knowles, B.B. & Wettstein, P.J. Immunological surveillance of tumours in the context of major histocompatability restriction of T-cell function. Adv. Cancer Res. 42, 1-65 (1984).
2. Yewdell, J.W. & Bennink, J.R. Cell biology of antigen processing and presentation to MHC class I molecule restricted T-lymphocytes. Adv. Immunol. 52, 1-42 (1992).
3. Tang, D.C., DeVit, M. & Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154 (1992).
4. Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1992).
5. Williams, R.S. et al. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc. Natl. Acad. Sci. USA 88, 2726-2730 (1991).
6. Fynan, E.F. et al. DNA vaccines: Protective immunization by parenteral, mucosal, and gene gun inoculation. Proc. Natl. Acad. Sci. USA 90, 11478-11482 (1993).
7. Donnelly, J.J. et al. Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nature Med. 1, 583-587 (1995).
8. Conroy, R.M. et al. A carcinoembryonic antigen polynucleotide vaccine has in vivo anti-tumour activity. Gene Ther. 2, 59-62 (1995).
9. Krishnan, S., Haensler, J. & Meulien, P. Paving the way towards DNA vaccines. Nature Med. 1, 521-522 (1995).
10. Pardoll, D.M. & Beckerleg, A.M. Exposing the immunology of naked DNA vaccines. Immunity 3, 165-169 (1995).
11. Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome to cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246 (1995).
12. Falo, L.D., Jr., Kovacsovics-Bankowski, M., Thompson, K. & Rock, K.L. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Med. 1, 649-653 (1995).
13. Suto, R. & Sirvastava, P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588 (1995).
14. Wolff, J.A. et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468 (1990).
15. Eisenbraun, M. D., Fuller, D.H. & Haynes, J.R. Examination of parameters effecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12, 791-797 (1993).
16. Yang, N.-S. & Sun, W.H. Gene gun and other non-viral approaches for cancer gene therapy. Nature Med. 1, 481-483 (1995).
17. Fidler, I.J., Gersten, D.M. & Budmen, M.B. Characteristics in vivo and in vitro of tumour cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 36, 3160-3165 (1976).
18. Pan, Z.K., Ikonomidis, G., Lazenby, A., Pardoll, D. & Paterson, Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nature Med. 1, 471-477 (1995).
19. Zhou, F., Rouse, B.T. & Huang L. Prolonged survival of thymoma bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: A model study. Cancer Res. 52, 6287-6291 (1992).
20. Huang, A.Y.C. et al. Role of bone marrow derived cells in presenting MHC class I restricted tumour antigens. Science 264, 961-965 (1994).
21. Moore, M.W., Carbone, F.R. & Bevan, M.J. Introduction of soluble proteins into the class I pathway of antigen processing and presentation. Cell 54, 777-785 (1988).
22. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T. & Falo, L.D., Jr. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287 (1996).
23. Van Wilsem, E.J.G., Breve, J., Kleijmeer, M. & Kraal, G. Antigen-bearing Langerhans cells in skin draining lymph nodes: Phenotype and kinetics of migration. J. Invest. Dermatol. 103, 217-220 (1994).
24. Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S. & Fryer, P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: Functional and morphological studies. J. Exp. Med. 166, 1654-1667 (1987).
25. Conroy, R.M. et al. Selected strategies to augment polynucleotide immunization. Gene Ther. 3, 67-74 (1996).
26. Ciernik, F.I., Brezofsky, J.A. & Carbone, D.P. Induction of cytotoxic T-lymphocytes and antitumor immunity with DNA vaccines expressing single T-cell epitopes. J. Immunol. 156, 2369-2375 (1996).
27. Irvine, K.R., Rao, J.B., Rosenberg, S.A. & Restifo, N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238-245 (1996).
28. Matsuno, K., Ezaki, T., Kudo, S. & Uehara, Y. A life stage of a particle-laden rat dendritic cell in vivo: Their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J. Exp. Med. 183, 1865-1878 (1996).
29. Huang, Y.C.A., Bruce, A.T., Pardoll, D.M. & Levitsky, H.I. In vivo cross-priming of MHC class I restricted antigens requires the TAP transporter. Immunity 4, 349-355 (1996).
30. Porgador, A. & Gilboa, E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255-258 (1995).
31. Porgador, A. & Gilboa, E. Induction of antitumor immunity using bone marrow generated dendritic cells. J. Immunol. 156, 2918-2926 (1996).
32. Mayordomo, J.I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1, 1297-1304 (1995).
33. Hsu, F.J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52-58 (1996).
34. Alijagic, S. et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 25, 3100-3107 (1995).